Blog Profile / PharmaGossip

Filed Under:Medical / Pharmaceutical
Posts on Regator:3991
Posts / Week:7.7
Archived Since:March 4, 2008

Blog Post Archive

AZ at it again

AUTH/2793/9/15 - Clinical pharmacist v AstraZeneca Case number:AUTH/2793/9/15 Case ref:Clinical pharmacist v AstraZeneca Description: Identifying patients suitable for Forxiga treatment and failing to provide an accurate response to the Panel No breach:No breaches Clauses 2 and 7.2 Breach:Breaches Clauses 3.2, 7.2 and 9.1. Show More Summary

Alltrials Latest

Dear AllTrials supporters You may have heard that Mark Zuckerberg, the founder of Facebook, and his wife Priscilla Chan have pledged $3 billion to medical research. That’s great news for patients and medical researchers worldwide – but only if this money is wisely spent. Show More Summary

Oh dear ASDA

Oh dear Asda......Posted by I Am Proud To Be British on Sunday, 26 October 2014

AllTrials update

Dear friend of AllTrials Over the past few weeks we've heard some great examples of what AllTrials supporters are doing to get all clinical trials registered and reported. Here’s what some of your fellow campaign supporters have been up to. Show More Summary

Marcia Angell writes

By Marcia Angell In 1953, a new drug was released by Burroughs Wellcome, a pharmaceutical company based in London. Pyrimethamine, as the compound was named, was originally intended to fight malaria after the microorganisms that cause the disease developed resistance to earlier therapies. Show More Summary

AllTrials in the USA

We’re excited to announce that 50 patient groups, consumer organisations and medical societies have come together to launch AllTrials USA today! These groups have said: "We are calling on everyone in our sector to join us in supporting the AllTrials campaign. Show More Summary

Richmond Pharmacology update

Here is a quick note about yesterday's hearing. Judgment is expected next week. The judge grasped the importance of trial registration and when he took into account our and the HRA's evidence on legal and ethical obligations to register trials he found that Richmond was left with an extraordinarily narrow argument. Show More Summary

Further Update

Hi AllTrials friends Yesterday we sent our submission to the court in the judicial review brought against the HRA by Richmond Pharmacology. We have spent the last few weeks ploughing through the hundreds of pages of documents. Richmond is currently asking the judge to rule that there is no overriding legal requirement to publicly register any trial. Show More Summary

AllTrials vs Richmond Pharmacology

Dear AllTrials friendWe hoped to tell you more about the case Richmond Pharmacology is bringing against the HRA. That's not been straightforward. Richmond has now changed their argument three times and has altogether abandoned some arguments...Show More Summary

Ben Goldacre writes in the BMJ - How medicine is broken, and how we can fix it

The chief medical officer’s review on statins and oseltamivir may look for answers in the wrong placesLast week there was extensive news coverage of a leaked letter written by the chief medical officer to the Academy of Medical Sciences. Show More Summary

A message from AllTrials about Richmond Pharmacology's Judicial Review

Dear AllTrials friend As most of you know Richmond Pharmacology has brought a judicial review against the Health Research Authority because it insists on the registration (not even reporting, but registration) of clinical trials. Read more. Show More Summary

Sidney Wolfe writes in the BMJ - AllTrials - Selective clinical trial reporting: betraying trial participants, harming patients

Reporting biases found in trials of cardiovascular devices Reporting biases in published trials were first identified in 1986. 1 Published randomized studies of combination chemotherapy compared with treatment with an alkylating agent as first line treatment for ovarian cancer showed a significant survival advantage for combination chemotherapy. Show More Summary

Introducing GlobalLeaks GlobaLeaks is an open source project aimed at creating a worldwide, anonymous, censorship-resistant, distributed whistleblowing platform.

From Evidence-Based Medicine to Marketing-Based Medicine

Dr Peter Parry is an Australian child & adolescent psychiatrist who has researched the "Pediatric Bipolar Disorder" diagnosis emanating from the USA, a diagnosis completely at odds with his training and clinical experience in Australian child and adolescent mental health. Show More Summary


WHO calls for increased transparency in medical research Note for the media 14 April 2015 14 APRIL | 2015 GENEVA - WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. Show More Summary

Copyright © 2015 Regator, LLC